Skip to content

Drug interactions

Sunitinib + Venetoclax

Severity: Moderate

Sunitinib and Venetoclax: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Venetoclax is a P-gp substrate and sunitinib may inhibit P-gp, potentially raising venetoclax exposure. This could increase neutropenia and tumour lysis risk.

What this interaction means in plain words

Sunitinib and Venetoclax can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sunitinib belongs to Oncology; Venetoclax belongs to Miscellaneous.

Evidence level: Low

Why it happens

Possible P-gp inhibition by sunitinib increases venetoclax exposure.

What to do

Monitor blood counts and tumour lysis parameters. Consider reducing the venetoclax dose if toxicity develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sunitinib and Venetoclax, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sunitinib with Venetoclax?

MediHelp rates the interaction as moderate. Sunitinib and Venetoclax can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Venetoclax is a P-gp substrate and sunitinib may inhibit P-gp, potentially raising venetoclax exposure. This could increase neutropenia and tumour lysis risk.

How serious is the interaction between Sunitinib and Venetoclax?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts and tumour lysis parameters. Consider reducing the venetoclax dose if toxicity develops.

What other medicines interact with Sunitinib?

MediHelp also lists interactions of Sunitinib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Sunitinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in